Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3039183	s-clteabg	— (—)	53	56	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

ILD medications

6.61

12.87

1.0

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

6.67

11.71

1.0

1.1

—

Immunodeficiency with predominantly antibody defects

+∞

10.43

1.1

0.0

—

First line medication for Crohn's disease

5.60

10.40

1.0

1.1

—

Chronic sinusitis

12.30

9.33

1.1

1.2

—

Other diseases of upper respiratory tract

6.51

9.28

1.0

1.1

—

Certain disorders involving the immune mechanism

24.02

8.90

1.2

1.0

—

5.84

8.56

1.2

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5.84

8.56

1.2

1.0

—

General symptoms and signs

5.25

8.37

1.1

1.0

—

Certain infectious and parasitic diseases

5.95

8.05

1.0

—

All pneumoniae

4.54

7.76

1.1

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4.65

7.68

1.2

1.0

—

Pneumonia, organism unspecified

4.82

7.65

1.2

1.0

—

Nonhereditary hypogammaglobulinemia

+∞

7.31

1.1

0.0

—

Acute upper respiratory infections of multiple and unspecified sites

4.96

7.22

1.0

—

Influenza and pneumonia

4.32

7.19

1.1

1.0

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

4.35

7.15

1.0

1.1

—

Chronic lower respiratory diseases

4.17

7.12

1.0

1.1

—

Diseases of oesophagus, stomach and duodenum

4.37

6.84

1.0

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

4.21

6.81

1.2

1.0

—

Acute upper respiratory infections

4.38

6.55

1.1

1.0

—

Acute sinusitis

6.32

6.46

1.1

1.0

—

Viral infections characterized by skin and mucous membrane lesions

7.37

6.39

1.0

1.1

—

Opioids

4.30

6.36

1.1

1.0

—

Kela reimbursement Agammaglobulinemia (D80-84)

+∞

6.27

1.3

0.0

—

Dorsopathies

4.22

6.18

1.0

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3.95

6.06

1.2

1.0

—

Pain in joint

7.82

5.97

1.1

1.0

—

Vasomotor and allergic rhinitis

9.77

5.93

1.0

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

15.00

5.90

1.1

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

8.26

5.89

1.0

1.1

—

Oral corticosteroids

3.98

5.83

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3.93

5.83

1.1

1.0

—

Medical observation and evaluation for suspected diseases and conditions

9.49

5.83

1.0

—

Other dorsopathies, not elsewhere classified

4.11

5.77

1.0

1.1

—

Gastro-oesophageal reflux disease

5.40

5.71

1.0

1.1

—

Diseases of the ear and mastoid process

3.76

5.66

1.0

1.1

—

COPD/asthma/ILD related infections

4.48

5.59

1.1

1.0

—

COPD/asthma related infections

4.48

5.59

1.1

1.0

—

Liquid cancers

12.17

5.39

1.1

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

8.90

5.29

1.1

1.0

—

Fever of other and unknown origin

6.25

5.28

1.2

1.0

—

Abnormalities of breathing

3.81

5.22

1.0

1.1

—

Liquid cancers, including Hilmo

11.33

5.16

1.1

1.0

—

Arthropathies

4.09

5.10

1.1

1.0

—

FESS (DNB20)

13.35

5.07

1.1

1.0

—

Ethmoidectomy

13.35

5.07

1.1

1.0

—

Any gastric operation

6.38

5.06

1.0

—

GASTRO-related operations

6.38

5.06

1.0

—

Disorders of eyelid, lacrimal system and orbit

3.78

5.01

1.1

—

Persons encountering health services in other circumstances, wide

3.62

4.95

1.1

1.0

—

Disorders of lacrimal system

5.90

4.83

1.1

1.0

—

Diseases of the skin and subcutaneous tissue

3.88

4.78

1.0

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

3.53

4.75

1.0

1.1

—

Other joint disorders

3.97

4.71

1.1

1.0

—

Episodal and paroxysmal disorders

3.44

4.63

1.0

1.1

—

3.51

4.50

1.1

1.0

—

Herpesviral [herpes simplex] infections, including avohilmo

6.67

4.46

1.0

—

Other specific joint derangements/joint disorders

4.45

4.40

1.1

1.0

—

Soft tissue disorders

3.48

4.24

1.1

1.0

—

Inflammatory bowel disease treatment related agents

3.22

4.15

1.1

—

Asthma/COPD (KELA code 203)

3.45

4.07

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

3.30

4.04

1.1

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

7.24

4.03

1.0

—

Cough

5.13

4.03

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases

3.29

4.02

1.1

1.0

—

Other disorders of lacrimal gland

5.56

3.97

1.1

1.0

—

Other intervertebral disc disorders

4.56

3.92

1.0

1.1

—

Diseases of the eye and adnexa

4.38

3.91

1.0

1.1

—

Headache

4.63

3.90

1.0

—

Acute suppurative otitis media

5.48

3.89

1.1

—

Asthma (diagnoses ohter than nonallergic)

3.19

3.83

1.0

1.1

—

Unspecified urinary incontinence

12.02

3.76

1.2

1.0

—

Asthma, including avohilmo

3.00

3.75

1.0

1.1

—

Suppurative and unspecified otitis media

4.64

3.70

1.1

1.0

—

Abnormal findings on diagnostic imaging of lung

5.68

3.64

1.0

—

Bronchitis

3.00

3.64

1.0

1.1

—

Sleep apnoea, including avohilmo

3.24

3.61

1.0

1.1

—

Autoimmune diseases

3.08

3.59

1.1

1.0

—

Dorsalgia

3.31

3.56

1.0

1.1

—

Other bacterial intestinal infections, including avohilmo

7.78

3.55

1.1

1.0

—

Dermatitis and eczema

2.96

3.55

1.0

1.1

—

Asthma, hospital admissions , main diagnosis only

3.12

3.54

1.0

1.1

—

Intestinal infectious diseases, including avohilmo, including avohilmo

2.86

3.50

1.1

1.0

—

Herpesviral [herpes simplex] infections

10.01

3.49

1.0

—

Cardiovascular diseases

3.63

3.49

1.0

1.1

—

Chronic diseases of tonsils and adenoids

4.62

3.48

1.0

1.1

—

4.20

3.47

1.0

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

3.61

3.46

1.1

—

Diseases of middle ear and mastoid

3.66

3.43

1.1

1.0

—

Disorders of synovium and tendon

4.71

3.43

1.0

1.1

—

Urinary track infection

3.62

3.40

1.0

—

Neurological diseases

3.35

3.32

1.0

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

7.77

3.27

1.0

—

Used for control exclusion in common control thyroid runs

2.99

3.23

1.0

—

Obesity related asthma

4.74

3.23

1.0

1.1

—

Any reimbursement code in KELA

5.64

3.18

1.0

—

Triptan medication for migraine, single purchase ok

2.90

3.18

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

2.90

3.18

1.1

—

Other diseases of urinary system

3.01

3.18

1.1

1.0

—

ILD medications: immunosuppressive drugs

4.53

3.08

1.0

1.1

—

Soft tissue disorders related to use, overuse and pressure

7.50

3.05

1.2

1.1

—

Pollen allergy

5.75

2.98

1.0

—

Other heart diseases, wide

2.84

2.97

1.1

—

Other heart diseases

3.76

2.95

1.1

—

Certain infectious and parasitic diseases, including avohilmo

5.01

2.95

1.0

—

Diseases of the musculoskeletal system and connective tissue

5.73

2.91

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

3.10

2.91

1.0

1.1

—

Asthma, hospital admission 2, infections

3.46

2.90

1.0

1.1

—

Asthma-related infections

3.46

2.90

1.0

1.1

—

Bacterial infection, other or unspecified

4.22

2.88

1.1

1.0

—

Other bacterial intestinal infections

6.67

2.86

1.2

1.0

—

Zoster [herpes zoster]

6.67

2.86

1.0

—

Bacterial intestinal infections, IBD co-morbidities

6.67

2.86

1.2

1.0

—

Myalgia

6.67

2.86

1.0

1.1

—

Finngen Rheumatological endpoints

2.75

2.78

1.0

1.1

—

Cystitis

2.97

2.77

1.2

1.0

—

Other soft tissue disorders, not elsewhere classified

2.96

2.71

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

6.00

2.69

1.0

1.1

—

Shoulder lesions

3.74

2.68

1.1

—

Examination and observation for other reasons

5.64

2.65

1.0

—

Benign neoplasm of colon, rectum, anus and anal canal

3.80

2.64

1.0

1.1

—

Any event in cancer register

2.72

2.59

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3.50

2.54

1.1

—

Pulmonary heart disease, diseases of pulmonary circulation

5.45

2.54

1.2

1.0

—

Septicaemia

4.56

2.51

1.3

1.0

—

Low back pain

3.37

2.48

1.0

1.1

—

Sleep apnoea

2.73

2.47

1.0

1.1

—

Cardiac arrhythmias

3.37

2.46

1.1

—

Autoimmune diseases related-to ILD

2.71

2.42

1.1

—

Premature rupture of membranes

4.53

2.40

1.0

—

Other and unspecified urticaria

5.00

2.40

1.0

—

Persons encountering health services for examination and investigation

5.02

2.39

1.0

—

Urticaria and erythema

3.33

2.39

1.0

—

Gonarthrosis

3.63

2.37

1.1

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2.65

2.35

1.1

—

Allergic rhinitis

3.29

2.35

1.0

—

Acute bronchitis

4.04

2.31

1.0

—

Artrosis, including avohilmo

3.01

2.30

1.0

1.1

—

Parasetamol

4.04

2.30

1.0

—

Other septicaemia

4.71

2.28

1.2

1.0

—

Other disorders of skin and subcutaneous tissue

2.81

2.28

1.0

1.1

—

Other septicaemia, including avohilmo

4.69

2.27

1.2

1.0

—

Other diseases of blood and blood-forming organs, wide

5.56

2.21

1.2

1.0

—

Anaemias

6.41

2.20

1.0

1.2

—

Atrial fibrillation and flutter with reimbursement

6.30

2.18

1.0

1.2

—

Tramadol

3.00

2.17

1.0

1.1

—

Abdominal and pelvic pain

2.74

2.15

1.0

—

Osteopathies and chondropathies

3.05

2.15

1.1

1.0

—

Symptoms and signs involving the urinary system

2.67

2.12

1.1

1.0

—

Pain (limb, back, neck, head abdominally)

3.64

2.11

1.0

—

Other acute lower respiratory infections

2.95

2.09

1.0

1.1

—

Dermatitis

2.93

2.08

1.0

1.1

—

Intestinal infectious diseases

2.41

2.08

1.1

—

Zoster [herpes zoster], including avohilmo

3.55

2.07

1.0

1.1

—

Ganglion

5.00

2.07

1.0

1.1

—

Implicit viral Sepsis

5.00

2.07

1.0

—

Viral Sepsis

5.00

2.07

1.0

—

Pulmonary embolism

5.00

2.07

1.2

1.0

—

Pulmonary heart disease

5.00

2.07

1.2

1.0

—

Visual disturbances and blindness

2.90

2.06

1.1

1.0

—

Bacterial infection, other or unspecified, including avohilmo

2.95

2.05

1.1

1.0

—

Systemic connective tissue disorders

3.50

2.05

1.1

1.0

—

Bacterial pneumonia (organism specified)

3.52

2.04

1.0

—

5.00

2.03

1.0

—

Asthma-related pneumonia

3.99

2.03

1.0

—

Asthma-related pneumonia or sepsis

3.99

2.03

1.0

—

Asthma, hospital admissions 3, pneumonia

3.99

2.03

1.0

—

Neoplasms

2.75

2.02

1.0

1.1

—

Arthrosis

3.08

2.02

1.0

—

Atrial fibrillation and flutter

4.30

2.01

1.2

1.1

—

COPD, hospital admission 2, with asthma infections

4.78

1.96

1.0

—

Renal tubulo-interstitial diseases

2.44

1.96

1.2

1.0

—

Sleep disorders (combined)

2.36

1.96

1.0

1.1

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

4.76

1.95

1.0

—

Nonsuppurative otitis media, including avohilmo

3.36

1.94

1.0

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

4.55

1.94

1.0

1.1

—

All influenza

4.55

1.94

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

3.75

1.93

1.2

1.0

—

Other and unspecified dermatitis

2.96

1.93

1.0

1.1

—

Conjunctivitis (acute, non atopic), including avohilmo

2.38

1.93

1.0

1.1

—

Nerve, nerve root and plexus disorders

2.36

1.90

1.0

1.1

—

Coxibs

5.25

1.88

1.0

1.2

—

Diabetes, varying definitions

2.35

1.87

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.70

1.87

1.0

1.1

—

Obesity due to excess calories

2.65

1.86

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2.31

1.86

1.1

1.0

—

Visual disturbances

2.86

1.86

1.0

—

Diabetes mellitus

2.34

1.86

1.1

—

Nonsuppurative otitis media

4.34

1.84

1.0

—

Benign neoplasm: Colon

3.13

1.83

1.0

1.1

—

Malignant neoplasm, including Hilmo

2.41

1.81

1.1

—

Malignant neoplasm, wide definition

2.41

1.81

1.1

—

Injuries to the shoulder and upper arm

2.42

1.80

1.1

—

Rotator cuff syndrome

3.21

1.80

1.1

—

Other diseases of intestines

2.23

1.79

1.1

—

Explicit Sepsis

3.03

1.77

1.3

1.0

—

Explicit Sepsis, including avohilmo

3.02

1.76

1.3

1.0

—

Dyspnoea

2.40

1.75

1.0

1.1

—

Other chronic obstructive pulmonary disease

4.09

1.74

1.0

—

Accidents

2.40

1.74

1.0

—

Other external causes of accidental injury

2.40

1.74

1.0

—

COPD

4.06

1.73

1.0

—

Lumbar disc prolapse

3.05

1.73

1.0

1.1

—

Exposure to unspecified factor

2.21

1.72

1.1

—

Symptoms and signs involving the digestive system and abdomen

2.50

1.72

1.0

—

Other enthesopathies

3.85

1.71

1.0

1.1

—

Implicit viral Sepsis, including avohilmo

3.84

1.71

1.0

—

Gastrointestinal diseases

3.19

1.69

1.0

1.1

—

Irregular menses

2.50

1.66

1.1

1.0

—

Covid-19 confirmed case

3.15

1.65

1.3

1.0

—

Polycystic ovarian syndrome, consortium definition

2.29

1.65

1.1

1.0

—

Benzodiazepine use

2.25

1.65

1.0

1.1

—

Urticaria

2.80

1.65

1.0

—

Lower back pain or/and sciatica

2.18

1.64

1.0

1.1

—

Gonarthrosis [arthrosis of knee](FG)

2.50

1.64

1.1

1.0

—

Sciatica+with lumbago

3.12

1.62

1.0

1.1

—

Other systemic involvement of connective tissue

3.57

1.61

1.2

1.0

—

Mycoses

3.57

1.61

1.0

—

Codeine

2.46

1.61

1.1

1.0

—

Other/unspecified dorsalgia

3.53

1.59

1.0

1.1

—

Heart failure and bmi 25plus

3.70

1.56

1.2

1.0

—

Maternal care for other known or suspected fetal problems

3.14

1.54

1.2

1.0

—

Pain in limb

2.60

1.52

1.0

—

DVT of lower extremities and pulmonary embolism

3.32

1.51

1.2

1.0

—

Spondylopathies

2.76

1.51

1.1

—

Diseases of oral cavity, salivary glands and jaws

2.77

1.48

1.0

—

Type 2 diabetes

2.17

1.48

1.1

—

All kidney diseases

2.11

1.45

1.2

1.0

—

All chronic kidney diseases

2.54

1.44

1.3

1.0

—

Malignant neoplasm

2.22

1.44

1.1

—

Malignant neoplasm

2.22

1.44

1.1

—

Other disorders of eyelid

3.14

1.43

1.0

—

Other headache syndromes

2.72

1.42

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.29

1.41

1.0

1.1

—

Other functional intestinal disorders

2.45

1.40

1.0

—

Heart failure,strict

3.17

1.39

1.2

1.0

—

Cholecystectomy

2.25

1.38

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2.17

1.38

1.0

1.1

—

Acute tubulo-interstitial nephritis

2.23

1.38

1.1

1.0

—

Obesity

2.17

1.35

1.1

—

Pain and other conditions associated with female genital organs and menstrual cycle

2.98

1.35

1.0

—

Obesity and other hyperalimentation

2.17

1.34

1.1

—

Diabetes medication

2.06

1.33

1.1

—

Bacterial Sepsis

2.95

1.33

1.2

1.0

—

Heart failure, not strict

2.44

1.31

1.1

1.0

—

Venous thromboembolism

2.51

1.30

1.2

1.0

—

Other nutritional deficiencies

2.11

1.30

1.1

—

Renal failure

2.84

1.29

1.4

1.0

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

2.78

1.28

1.2

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

2.78

1.28

1.2

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

2.33

1.28

1.0

1.1

—

Infections of the skin and subcutaneous tissue

2.31

1.27

1.1

—

Complications of procedures, not elsewhere classified

2.12

1.27

1.0

1.1

—

COPD, hospital admissions

2.81

1.27

1.0

—

Persons encountering health services in other circumstances

2.75

1.27

1.0

—

COPD, early/later onset

2.80

1.26

1.0

—

Malaise and fatigue

2.81

1.26

1.0

—

Temporomandibular joint disorders, including avohilmo

2.28

1.26

1.0

1.1

—

Spondylosis

2.79

1.25

1.0

1.1

—

Maternal care for known or suspected abnormality of pelvic organs

2.81

1.23

1.0

—

Other disorders of urethra and urinary system

2.23

1.22

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

2.04

1.21

1.0

1.1

—

Disturbances of skin sensation

2.63

1.21

1.0

—

Haemorrhoids and perianal venous thrombosis

2.61

1.20

1.2

1.1

—

Mycoses, including avohilmo

1.99

1.20

1.0

1.1

—

Other diseases of lip and oral mucosa

2.31

1.18

1.0

—

Endocrine, nutritional and metabolic diseases

2.06

1.18

1.0

1.1

—

Biguanides

2.01

1.17

1.0

1.1

—

Polyarthropathies

2.50

1.16

1.1

1.0

—

Dental pulpitis, including avohilmo

1.92

1.16

1.0

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

2.56

1.16

1.0

—

Disorders of lens

2.41

1.14

1.1

—

Other arrhythmias

2.06

1.13

1.0

1.1

—

Primary gonarthrosis, bilateral

2.46

1.11

1.0

—

External causes of morbidity and mortality

2.15

1.10

1.0

—

Other (not insulin) diabetes medications

1.96

1.09

1.1

—

All-cause Heart Failure

2.48

1.09

1.2

1.0

—

Heart failure, strict

2.48

1.09

1.2

1.0

—

Complications of surgical and medical care, not elsewhere classified

1.93

1.09

1.0

1.1

—

Gonarthrosis,primary

2.09

1.08

1.1

1.0

—

Female infertility, cervical, vaginal, other or unspecified origin

2.46

1.07

1.0

—

Solid cancers, including Hilmo

2.01

1.06

1.0

1.1

—

Persons encountering health services for specific procedures and health care

1.86

1.06

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

2.27

1.03

1.0

—

Disorders of refraction and accommodation

2.26

1.03

1.0

—

Inflammatory diseases of female pelvic organs

1.92

1.02

1.1

1.0

—

Provisional assignment of new diseases of uncertain etiology

2.04

1.02

1.3

1.0

—

Codes for special purposes

2.04

1.02

1.3

1.0

—

Other and unspecified disorders of vitreous body

2.22

1.00

1.2

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

2.00

1.00

1.0

1.1

—

Postpartum haemorrhage

0.00

0.99

0.0

1.0

—

Postpartum hemorraghe, parous women as controls

0.00

0.99

0.0

1.0

—

Disorders of breast

1.99

0.98

1.0

1.1

—

Gestational diabetes (for exclusion)

2.01

0.98

1.1

1.0

—

Type 2 diabetes, strict (exclude DM1)

1.94

0.98

1.1

—

Type 2 diabetes, definitions combined

1.94

0.98

1.1

—

Lyme disease

2.17

0.98

1.0

—

Lyme disease, including avohilmo

2.17

0.98

1.0

—

Spirochaetal infections, other/unspecified, including avohilmo

2.17

0.98

1.0

—

Other spirochaetal diseases

2.17

0.98

1.0

—

Other spirochaetal diseases, including avohilmo

2.17

0.98

1.0

—

Other bacterial diseases, including avohilmo

1.85

0.98

1.2

1.0

—

Senile cataract

2.43

0.97

1.0

1.1

—

Contact with and exposure to communicable diseases

0.00

0.97

0.0

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

0.00

0.97

0.0

1.0

—

Benign neoplasms

1.94

0.97

1.0

1.1

—

Postpartum hemorraghe, all women as controls

0.00

0.97

0.0

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

1.93

0.96

1.1

—

Dentofacial anomalies [including malocclusion]

1.80

0.96

1.0

1.1

—

Solid cancers

1.82

0.96

1.0

1.1

—

Other bacterial diseases

1.89

0.95

1.2

1.0

—

Second line medication for Crohn's disease

1.89

0.94

1.0

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

1.77

0.90

1.0

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.94

0.89

1.1

1.0

—

Other disorders of ear

1.85

0.89

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

1.89

0.88

1.1

—

Caries of dentine, including avohilmo

1.86

0.86

1.0

1.1

—

Missing teeth due to accident, extraction or parodontitis

1.98

0.86

1.0

1.1

—

Pain in throat and chest

1.82

0.85

1.0

1.1

—

Migraine

1.94

0.84

1.0

1.1

—

Single spontaneous delivery

0.00

0.83

0.0

1.1

—

Carpal tunnel syndrome

1.92

0.83

1.0

1.1

—

Artificial joint operation, meniscal resection

1.76

0.82

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1.73

0.82

1.1

1.0

—

Injuries to the hip and thigh

0.00

0.79

0.0

1.0

—

Hypertensive diseases

1.75

0.77

1.0

—

Hypertension

1.75

0.77

1.0

—

Cholelithiasis

1.75

0.77

1.1

—

Diseases of pulp and periapical tissues and dental caries

1.89

0.75

1.0

1.1

—

Neurotic, stress-related and somatoform disorders

1.72

0.75

1.0

1.1

—

Cholelithiasis, broad definition with cholecystitis

1.66

0.74

1.1

—

Atopic dermatitis

1.86

0.74

1.0

1.1

—

Hypothyroidism, strict autoimmune

1.84

0.74

1.1

1.0

—

Anxiety disorders, excluding more controls

1.64

0.73

1.0

1.1

—

Depression or dysthymia

1.82

0.73

1.1

1.0

—

Recurrent or chronic depression

2.04

0.73

1.2

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.81

0.72

1.0

1.1

—

Disorders of conjunctiva

1.62

0.72

1.0

1.1

—

Disorders of vitreous body

1.98

0.72

1.2

1.0

—

Disorders of skin appendages

1.79

0.72

1.1

1.0

—

Disease of hard tissues of teeth, NOS

2.01

0.72

1.0

—

Disorders of vitreous body and globe

1.97

0.72

1.2

1.0

—

Dermatophytosis, including avohilmo

1.76

0.71

1.0

1.1

—

Allergic conjunctivitis

1.73

0.70

1.0

1.1

—

Diseases of arteries, arterioles and capillaries

1.93

0.70

1.0

1.1

—

Dental caries, including avohilmo

1.71

0.69

1.0

1.1

—

Anxiety disorders

1.67

0.69

1.0

1.1

—

Hernia of abdominal wall

1.79

0.66

1.0

—

Varicose veins

1.80

0.66

1.0

—

Complications of medical and surgical care

1.61

0.66

1.0

1.1

—

Injuries to the knee and lower leg

1.58

0.65

1.1

1.0

—

Noninflammatory disorders of female genital tract

1.79

0.64

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.72

0.64

1.0

—

Diseases of inner ear

1.71

0.63

1.0

—

Pregnancy with abortive outcome

1.60

0.62

1.0

1.1

—

Hypertensive diseases (excluding secondary)

1.84

0.60

1.0

1.1

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.60

0.0

1.0

—

Alcohol use disorder, ICD-based

0.00

0.60

0.0

1.1

—

Dental operations

1.81

0.60

1.0

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

0.00

0.60

0.0

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

0.00

0.60

0.0

1.0

—

Schizophrenia or delusion

0.00

0.59

0.0

1.0

—

Schizophrenia, schizotypal and delusional disorders

0.00

0.59

0.0

1.0

—

Conjunctivitis

1.53

0.59

1.0

1.1

—

Non-selective monoamine reuptake inhibitors

0.00

0.58

0.0

1.0

—

Schizophrenia or delusion, excluding more controls

0.00

0.58

0.0

1.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.67

0.57

1.0

—

Sensorineural hearing loss

1.67

0.56

1.0

—

Disorders of gallbladder, biliary tract and pancreas

1.55

0.56

1.1

—

Chronic apical periodontitis

1.54

0.56

1.0

1.1

—

Diverticular disease of intestine

1.62

0.55

1.0

1.1

—

Diabetes mellitus in pregnancy

1.59

0.54

1.2

1.0

—

L04AX Other immunosuppressants

1.58

0.54

1.0

1.1

—

Use of hypnotics and sedatives

1.47

0.54

1.0

1.1

—

Necrosis of pulp, including avohilmo

1.56

0.53

1.0

1.1

—

Disorders of the thyroid gland

1.46

0.53

1.1

—

Conductive and sensorineural hearing loss

1.53

0.52

1.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.52

0.52

1.2

1.0

—

Dislocation, sprain and strain of joints and ligaments of knee

1.51

0.51

1.0

1.1

—

Antihypertensive medication - note that there are other indications

1.46

0.47

1.1

1.0

—

Triptan medication for migraine, min. 3 purchases

1.45

0.46

1.1

1.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.62

0.43

1.0

—

Outcome of delivery

0.00

0.42

0.0

1.0

—

Myocardial infarction, strict

0.00

0.42

0.0

1.1

—

Insulin medication

1.54

0.41

1.0

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.37

0.41

1.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.41

0.0

1.1

—

Noninfective enteritis and colitis

1.51

0.41

1.0

1.1

—

Migraine without aura and triptan purchases

0.00

0.41

0.0

1.0

—

Bipolar affective disorders

0.00

0.41

0.0

1.1

—

Coxarthrosis, primary, with hip surgery

0.00

0.40

0.0

1.0

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.40

0.0

1.1

—

Nonorganic sleeping disorders

0.00

0.40

0.0

1.0

—

Poisoning by drugs, medicaments and biological substances

0.00

0.40

0.0

1.0

—

Perineal laceration during delivery

0.00

0.40

0.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

0.00

0.40

0.0

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.42

0.39

1.0

1.1

—

Suicide or other Intentional self-harm

0.00

0.39

0.0

1.0

—

Nonorganic sleeping disorders, excluding more controls

0.00

0.39

0.0

1.1

—

Injuries to the wrist and hand

1.36

0.38

1.0

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.40

0.38

1.0

1.1

—

Spontaneous abortion

1.39

0.38

1.0

1.1

—

Codeine or tramadol medication

1.43

0.38

1.1

—

Percutaneous Coronary Intervention

1.35

0.34

1.0

1.1

—

Coronary revascularization (ANGIO or CABG)

1.35

0.34

1.0

1.1

—

Disorders of choroid and retina

1.31

0.33

1.0

1.1

—

Hypertension, essential

1.41

0.32

1.0

—

Exposure to other specified factors

1.31

0.30

1.0

1.1

—

Falls/tendency to fall

1.35

0.29

1.0

1.1

—

Metabolic disorders

1.33

0.29

1.0

1.1

—

Mood disorders, excluding more controls

1.31

0.29

1.1

—

Insomnia

1.29

0.28

1.0

1.1

—

Depression

1.24

0.27

1.1

1.0

—

Other antidepressants

1.28

0.26

1.0

1.1

—

Any mental disorder

1.25

0.26

1.0

1.1

—

Injury, poisoning and certain other consequences of external causes

1.39

0.24

1.0

1.1

—

Type 2 diabetes, wide definition

1.31

0.23

1.0

—

Other neurological diseases

1.25

0.22

1.0

1.1

—

Ischaemic heart disease, wide definition

1.23

0.22

1.0

1.1

—

Any dementia

0.00

0.22

0.0

1.0

—

Alzheimer disease, including avohilmo

0.00

0.22

0.0

1.0

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.21

0.0

1.0

—

Implicit Sepsis

1.19

0.21

1.0

—

Eating disorder

0.00

0.21

0.0

1.0

—

Fracture of lumbar spine and pelvis

0.00

0.21

0.0

1.0

—

Eating disorders

0.00

0.21

0.0

1.0

—

0.00

0.21

0.0

1.0

—

Postpartum haemorrhage due to anatomy

0.00

0.21

0.0

1.1

—

Spondyloarthritis

0.00

0.21

0.0

1.0

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.21

0.0

1.0

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.21

0.0

1.0

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

0.21

0.0

1.0

—

Other (seronegative) rheumatoid arthritis, wide

0.00

0.21

0.0

1.0

—

Nontoxic multinodular goitre

0.00

0.21

0.0

1.0

—

Acute appendicitis, with complications

0.00

0.21

0.0

1.0

—

Sequelae with surgical and medical care as external cause

0.00

0.21

0.0

1.0

—

Focal epilepsy

0.00

0.21

0.0

1.0

—

Combinations of oral blood glucose lowering drugs

0.00

0.21

0.0

1.0

—

Fracture of skull and facial bones

0.00

0.21

0.0

1.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

0.21

0.0

1.0

—

Other/unspecified seropositive rheumatoid arthritis

0.00

0.21

0.0

1.0

—

Seropositive rheumatoid arthritis, wide

0.00

0.21

0.0

1.0

—

Sequelae of external causes of morbidity and mortality

0.00

0.21

0.0

1.0

—

Alcohol dependence

0.00

0.21

0.0

1.0

—

Superficial injury of abdomen, lower back and pelvis

0.00

0.21

0.0

1.0

—

L02BA Anti-estrogens

0.00

0.21

0.0

1.0

—

Other and unspecified nonorganic psychotic disorders

0.00

0.21

0.0

1.0

—

Sulfasalazine

0.00

0.21

0.0

1.0

—

Prolonged pregnancy

0.00

0.21

0.0

1.0

—

Emergency coronary revascularization (for ACS)

1.29

0.21

1.0

1.1

—

Ischemic heart diseases

1.27

0.21

1.0

1.1

—

Postpartum haemorrhage due to retained placenta

0.00

0.21

0.0

1.1

—

Pedal cyclist injured in transport accident

0.00

0.21

0.0

1.0

—

Primary coxarthrosis, bilateral

0.00

0.21

0.0

1.0

—

Other diseases of the digestive system

0.00

0.21

0.0

1.0

—

GI-bleeding

0.00

0.21

0.0

1.0

—

Medical abortion

1.25

0.20

1.0

1.1

—

Fall on same level

1.27

0.20

1.1

1.0

—

Dizziness and giddiness

1.26

0.20

1.0

1.1

—

All anxiety disorders

1.26

0.20

1.0

1.1

—

Poisoning by medicine

0.00

0.20

0.0

1.0

—

Sequelae of injuries, of poisoning and of other consequences of external causes

0.00

0.20

0.0

1.0

—

Migraine without aura

0.00

0.20

0.0

1.1

—

Tonsillectomy and adenotomy

1.23

0.20

1.0

—

Anxiety (asthma-related co-morbidities)

1.23

0.20

1.0

1.1

—

Epilepsy

0.00

0.20

0.0

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

1.22

0.20

1.0

1.1

—

Myocardial infarction, without ST-elevation

0.00

0.20

0.0

1.0

—

Other maternal disorders predominantly related to pregnancy

1.21

0.20

1.0

—

Injuries to the ankle and foot

1.14

0.19

1.0

1.1

—

Hernia

1.22

0.18

1.0

1.1

—

Hypothyroidism, other/unspecified

1.21

0.18

1.1

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.16

0.18

1.0

1.1

—

Sleep disorders

1.12

0.17

1.0

1.1

—

Mood [affective] disorders

1.16

0.17

1.1

1.0

—

Mood disorders

1.16

0.16

1.1

1.0

—

Injuries to the head

0.76

0.16

1.0

1.1

—

Excessive attrition of teeth

1.15

0.10

1.0

1.1

—

Major coronary heart disease event

1.07

0.09

1.0

1.1

—

Implicit Sepsis, including avohilmo

1.05

0.09

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.06

0.08

1.2

1.0

—

Psychiatric diseases

1.10

0.08

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.12

0.08

1.1

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.08

0.08

1.0

1.1

—

Caries of enamel

1.06

0.08

1.0

1.1

—

Gingivitis and periodontal diseases

1.03

0.08

1.0

—

Coronary artery bypass grafting

0.00

0.0

1.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

1.0

—

Nontraumatic intracranial haemmorrhage

0.00

0.0

1.0

—

Other eating disorders

0.00

0.0

1.0

—

Superficial injury of hip and thigh

0.00

0.0

1.0

—

Enthesopathies of lower limb, excluding foot

0.00

0.0

1.0

—

Thyroiditis, ILD-related definition

0.00

0.0

1.0

—

Benign neoplasm of breast

0.00

0.0

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.0

1.0

—

Superficial injury of thorax

0.00

0.0

1.0

—

Alzheimer’s disease (Late onset)

0.00

0.0

1.0

—

Other condition

0.00

0.0

1.0

—

Other problems related to primary support group, including family circumstances

0.00

0.0

1.0

—

Other and unspecified vascular occlusions

0.00

0.0

1.0

—

Other disorders of the musculoskeletal system and connective tissue

0.00

0.0

1.0

—

Mandibular retrognathia

0.00

0.0

1.0

—

Personal history of malignant neoplasm

0.00

0.0

1.0

—

Ménière disease

0.00

0.0

1.0

—

Other and/or unspecified nontoxic goitre

0.00

0.0

1.0

—

Vestibular neuronitis

0.00

0.0

1.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

0.00

0.0

1.0

—

Alzheimer’s disease, strict definition

0.00

-0.00

0.0

1.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

0.00

-0.00

0.0

1.0

—

Disorders of optic nerve and visual pathways

0.00

-0.00

0.0

1.0

—

Use of memantine

0.00

-0.00

0.0

1.0

—

Use of donepezil

0.00

-0.00

0.0

1.0

—

Agranulocytosis

0.00

-0.00

0.0

1.0

—

Use of other anti-dementia drugs

0.00

-0.00

0.0

1.0

—

Ocular pain

0.00

-0.00

0.0

1.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.00

-0.00

0.0

1.0

—

Unspecified kidney failure

0.00

-0.00

0.0

1.0

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

0.00

-0.00

0.0

1.0

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

-0.00

0.0

1.0

—

Graves disease, strict definition

0.00

-0.00

0.0

1.0

—

Deep bite

0.00

-0.00

0.0

1.0

—

Aortic aneurysm

0.00

-0.00

0.0

1.0

—

Complications of labour and delivery

0.93

-0.00

1.0

1.1

—

Cholecystitis

0.00

-0.00

0.0

1.0

—

DVT of lower extremities

0.00

-0.00

0.0

1.0

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Status post-ami

0.00

-0.00

0.0

1.0

—

Any dementia, excluding more controls

0.00

-0.00

0.0

1.0

—

Chronic periodontitis, including avohilmo

0.98

-0.00

1.2

1.1

—

Macular pucker

0.00

-0.00

0.0

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

0.96

-0.00

1.0

—

Hard cardiovascular diseases

0.92

-0.00

1.0

1.1

—

Memory loss

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of breast, HER-negative

0.00

-0.00

0.0

1.0

—

Parkinson's disease, strict definition

0.00

-0.00

0.0

1.0

—

Hypertensive heart and/or renal disease

0.00

-0.00

0.0

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.01

-0.00

1.0

1.1

—

Injuries to unspecified part of trunk, limb or body region

0.00

-0.00

0.0

1.0

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

-0.00

0.0

1.0

—

Other disorders of eye and adnexa

0.00

-0.00

0.0

1.0

—

Abnormal findings on antenatal screening of mother

0.00

-0.00

0.0

1.0

—

Peripheral artery operations in Hilmo

0.00

-0.00

0.0

1.0

—

Amenorrhoea

0.00

-0.00

0.0

1.0

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

0.00

-0.00

0.0

1.0

—

Other respiratory disorders and diseases

0.00

-0.00

0.0

1.0

—

Other metabolic disorders

0.00

-0.00

0.0

1.0

—

Rash and other nonspecific skin eruption

0.00

-0.00

0.0

1.0

—

Other puerperal infections

0.00

-0.00

0.0

1.0

—

Acute and transient psychotic disorders

0.00

-0.00

0.0

1.0

—

Retinal vascular disorders

0.00

-0.00

0.0

1.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

0.00

-0.00

0.0

1.0

—

Retinal vascular occlusion

0.00

-0.00

0.0

1.0

—

Speech and linguistic disorders, excluding more controls

0.00

-0.00

0.0

1.0

—

Parkinson's disease, strict definition, excluding more controls

0.00

-0.00

0.0

1.0

—

Personal history of other diseases and conditions

0.00

-0.00

0.0

1.0

—

Restless leg syndrome

0.00

-0.00

0.0

1.0

—

Family history of malignant neoplasm

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of breast, ER-negative, including Hilmo

0.00

-0.00

0.0

1.1

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.0

—

Overexertion and strenuous or repetitive movements

0.00

-0.00

0.0

1.0

—

Pedal cyclist injured in noncollision transport accidents

0.00

-0.00

0.0

1.0

—

Traumatic subdural haemorrhage

0.00

-0.00

0.0

1.0

—

Bitten or struck by other mammals

0.00

-0.00

0.0

1.0

—

Focal epilepsy, strict definition

0.00

-0.00

0.0

1.0

—

Alzheimer disease

0.00

-0.00

0.0

1.0

—

Bell's palsy

0.00

-0.00

0.0

1.0

—

Parkinson's disease, excluding more controls

0.00

-0.00

0.0

1.0

—

Seronegative rheumatoid arthritis

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at hip and thigh level

0.00

-0.00

0.0

1.0

—

Fracture of femur

0.00

-0.00

0.0

1.0

—

Ulcerative rectosigmoiditis

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Caecum

0.00

-0.00

0.0

1.0

—

Superficial injury of forearm

0.00

-0.00

0.0

1.0

—

Seropositive rheumatoid arthritis

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of lower limb

0.00

-0.00

0.0

1.0

—

Thyrotoxicosis with toxic multinodular goitre

0.00

-0.00

0.0

1.0

—

Dementia in Alzheimer disease

0.00

-0.00

0.0

1.0

—

Delirium, not induced by alcohol and other psychoactive substances

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of upper limb

0.00

-0.00

0.0

1.0

—

Other mental disorders due to brain damage and dysfunction and to physical disease

0.00

-0.00

0.0

1.0

—

Emotionally unstable personality disorder

0.00

-0.00

0.0

1.0

—

Ill-defined and unknown causes of mortality

0.00

-0.00

0.0

1.0

—

Selective serotonin reuptake inhibitors

0.87

-0.00

1.0

1.1

—

Other disorders of cornea

0.00

-0.00

0.0

1.0

—

Other inflammation of eyelid

0.00

-0.00

0.0

1.0

—

Use of levodopa decarboxylase inhibitor

0.00

-0.00

0.0

1.0

—

Other obstructed labour

0.00

-0.00

0.0

1.0

—

Placenta praevia

0.00

-0.00

0.0

1.0

—

severe traumatic brain injury, does not include concussion

0.00

-0.00

0.0

1.0

—

Wet age-related macular degeneration

0.00

-0.00

0.0

1.0

—

Gastric ulcer

0.00

-0.00

0.0

1.0

—

Gastroduodenal ulcer

0.00

-0.00

0.0

1.0

—

Nephropathy related operations

0.00

-0.00

0.0

1.0

—

Monoamine oxidase A inhibitors

0.00

-0.00

0.0

1.0

—

Other noninflammatory disorders of vulva and perineum

0.00

-0.00

0.0

1.0

—

KRA_PSY_EATING, excluding more controls

0.00

-0.00

0.0

1.0

—

Speech and linguistic disorders

0.00

-0.00

0.0

1.0

—

Periodontitis

0.98

-0.00

1.2

1.1

—

Constipation

0.85

-0.00

1.0

1.1

—

Acute gastritis

0.00

-0.00

0.0

1.0

—

Other diseases of the respiratory system

0.00

-0.00

0.0

1.0

—

Other diseases of stomach and duodenum

0.00

-0.00

0.0

1.0

—

Myocardial infarction, with ST-elevation

0.00

-0.00

0.0

1.0

—

Crowding of teeth, including avohilmo

0.00

-0.00

0.0

1.0

—

Retinal detachment with retinal break

0.00

-0.00

0.0

1.0

—

Colon adenocarcinoma, helper endpoint

0.00

-0.00

0.0

1.0

—

Insulin, fast-acting (human)

0.00

-0.00

0.0

1.0

—

Degenerative macular diseases

0.00

-0.00

0.0

1.0

—

Unspecified/other endometriosis

0.00

-0.00

0.0

1.0

—

Benign mammary dysplasia

0.00

-0.00

0.0

1.0

—

Deep endometriosis

0.00

-0.00

0.0

1.0

—

Endometriosis of rectovaginal septum and vagina

0.00

-0.00

0.0

1.0

—

Female infertility, tubal origin

0.00

-0.00

0.0

1.0

—

Impacted cerumen

0.00

-0.00

0.0

1.0

—

Other disorders of kidney and ureter

0.00

-0.00

0.0

1.0

—

Thoracic aortic aneurysm

0.00

-0.00

0.0

1.0

—

Vitreous haemorrhage

0.00

-0.00

0.0

1.0

—

Subarachnoid haemorrhage

0.00

-0.00

0.0

1.0

—

Parkinson's disease, including avohilmo

0.00

-0.00

0.0

1.0

—

Other specified and unspecified personality disorders

0.00

-0.00

0.0

1.0

—

Schizophrenia

0.00

-0.00

0.0

1.0

—

Benign neoplasm of major salivary glands

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Stomach

0.00

-0.00

0.0

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

0.00

-0.00

0.0

1.0

—

Degenerative diseases of the nervous system

0.00

-0.00

0.0

1.0

—

Transient global amnesia

0.00

-0.00

0.0

1.0

—

Parkinson's disease

0.00

-0.00

0.0

1.0

—

Congenital malformations of genital organs

0.00

-0.00

0.0

1.0

—

Other noninflammatory disorders of vagina

0.00

-0.00

0.0

1.0

—

Excessive vomiting in pregnancy

0.00

-0.00

0.0

1.0

—

Other blood glucose lowering drugs, excl. Insulins

0.00

-0.00

0.0

1.0

—

Noninfectious colitis NAS

0.00

-0.00

0.0

1.0

—

Maternal care for known or suspected disproportion

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

-0.00

0.0

1.0

—

Hypertensive Heart Disease

0.00

-0.00

0.0

1.0

—

Benign leiomyoma with endometriosis

0.00

-0.00

0.0

1.0

—

Benign neoplasm of mouth and pharynx

0.00

-0.00

0.0

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

-0.00

0.0

1.0

—

Methotrexate

0.00

-0.00

0.0

1.0

—

Amputation

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS